Cargando…

Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III

BACKGROUND: SafeBoosC-III is an international randomised clinical trial to evaluate the effect of treatment of extremely preterm infants during the first 3 days of life based on cerebral near-infrared spectroscopy (NIRS) monitoring versus treatment and monitoring as usual. To ensure high quality of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Mathias Lühr, Rasmussen, Marie Isabel, Rubin, Snorre, Pellicer, Adelina, Cheng, Guoqiang, Xu, Xin, Zhaoqing, Yin, Zoffmann, Vibeke, Greisen, Gorm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181533/ https://www.ncbi.nlm.nih.gov/pubmed/32326953 http://dx.doi.org/10.1186/s13063-020-4206-6

Ejemplares similares

Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
por: Olsen, Markus Harboe, et al.
Publicado: (2021)

Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury
por: Plomgaard, Anne M., et al.
Publicado: (2016)

The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial
por: Vestager, Maria Linander, et al.
Publicado: (2023)

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial
por: Plomgaard, Anne M., et al.
Publicado: (2017)

The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings
por: Riera, Joan, et al.
Publicado: (2016)

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life
por: Plomgaard, Anne M., et al.
Publicado: (2018)

Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown
por: Rasmussen, Marie Isabel, et al.
Publicado: (2021)

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial
por: Plomgaard, Anne Mette, et al.
Publicado: (2022)

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial
por: Rasmussen, Marie Isabel, et al.
Publicado: (2023)

Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments
por: Plomgaard, Anne M, et al.
Publicado: (2016)

Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
por: Olsen, Markus Harboe, et al.
Publicado: (2023)

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2013)

Peripheral tissue oximetry: comparing three commercial near-infrared spectroscopy oximeters on the forearm
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2013)

Cerebral oxygenation after birth – a comparison of INVOS(®) and FORE‐SIGHT™ near‐infrared spectroscopy oximeters
por: Hessel, Trine W., et al.
Publicado: (2014)

Has the time come to use near-infrared spectroscopy as a routine clinical tool in preterm infants undergoing intensive care?
por: Greisen, Gorm, et al.
Publicado: (2011)

The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis
por: Hansen, Mathias Lühr, et al.
Publicado: (2021)

Dedicated near-infrared oximeter to monitor oxygenation in the superior sagittal sinus in newborn infants: a research agenda
por: Greisen, Gorm
Publicado: (2022)

Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2015)

Near-surface effects in modelling oscillations of $\eta$ Boo
por: Christensen-Dalsgaard, J, et al.
Publicado: (1995)

Disappointment and adherence among parents of newborns allocated to the control group: a qualitative study of a randomized clinical trial
por: Meinich Petersen, Sandra, et al.
Publicado: (2014)

Erratum to: Disappointment and adherence among parents of newborns allocated to the control group: a qualitative study of a randomized clinical trial
por: Petersen, Sandra Meinich, et al.
Publicado: (2015)

Cerebrovascular reactivity to carbon dioxide tension in newborns: data from combined time-resolved near-infrared spectroscopy and diffuse correlation spectroscopy
por: Passera, Sofia, et al.
Publicado: (2023)

Assessment of BPH/BOO
por: Mangera, Altaf, et al.
Publicado: (2014)

Cerebral Oximetry in Preterm Infants–To Use or Not to Use, That Is the Question
por: Greisen, Gorm, et al.
Publicado: (2022)

UV spectrum of $\lambda$ Boo
por: Gerbaldi, M, et al.
Publicado: (1995)

Management of the complications of BPH/BOO
por: Speakman, Mark J., et al.
Publicado: (2014)

“Boo-Khar”—India Fever
por: Condict, Alice B.
Publicado: (1889)

MicroBooNE and the $\nu_e$ Interpretation of the MiniBooNE Low-Energy Excess
por: Argüelles, C.A., et al.
Publicado: (2021)

Behavioural and neurodevelopmental impairment at school age following necrotising enterocolitis in the newborn period
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Boo-boos as the building blocks of pain expression: An observational examination of parental responses to everyday pain in toddlers
por: Noel, Melanie, et al.
Publicado: (2018)

Non-Hormonal treatment of BPH/BOO
por: Osman, Nadir I., et al.
Publicado: (2014)

Near-Infrared Spectroscopy in Bio-Applications
por: Beć, Krzysztof B., et al.
Publicado: (2020)

Rapid on-line detection and grading of wooden breast myopathy in chicken fillets by near-infrared spectroscopy
por: Wold, Jens Petter, et al.
Publicado: (2017)

Dopamine therapy does not affect cerebral autoregulation during hypotension in newborn piglets
por: Eriksen, Vibeke Ramsgaard, et al.
Publicado: (2017)

Modelling solar-like oscillations in $\eta$ Boo
por: Christensen-Dalsgaard, J, et al.
Publicado: (1994)

DSLs in Boo: domain-specific languages in .NET
por: Rahien, Ayende
Publicado: (2010)

Fermilab: MiniBooNE opens the box
Publicado: (2007)

Functional near-infrared spectroscopy studies in children
por: Nagamitsu, Shinichiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g3so1h1j21i1pt4be1lukbqmfv